[go: up one dir, main page]

UA97971C2 - Препарат невирапина пролонгированного высвобождения - Google Patents

Препарат невирапина пролонгированного высвобождения

Info

Publication number
UA97971C2
UA97971C2 UAA200908230A UAA200908230A UA97971C2 UA 97971 C2 UA97971 C2 UA 97971C2 UA A200908230 A UAA200908230 A UA A200908230A UA A200908230 A UAA200908230 A UA A200908230A UA 97971 C2 UA97971 C2 UA 97971C2
Authority
UA
Ukraine
Prior art keywords
nevirapine
extended release
release formulation
pharmaceutical composition
relates
Prior art date
Application number
UAA200908230A
Other languages
English (en)
Ukrainian (uk)
Inventor
Майкл Л. Каппола
Светлана Синкевич
Гленн Чарлз Сноу
Фен-Цзин Чень
Original Assignee
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39739795&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA97971(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Берингер Ингельхайм Интернациональ Гмбх filed Critical Берингер Ингельхайм Интернациональ Гмбх
Publication of UA97971C2 publication Critical patent/UA97971C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В заявке описана фармацевтическая композиция пролонгированного высвобождения, содержащая невирапин.
UAA200908230A 2007-06-08 2008-06-04 Препарат невирапина пролонгированного высвобождения UA97971C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94276507P 2007-06-08 2007-06-08
PCT/US2008/065705 WO2008154234A2 (en) 2007-06-08 2008-06-04 Extended release formulation of nevirapine

Publications (1)

Publication Number Publication Date
UA97971C2 true UA97971C2 (ru) 2012-04-10

Family

ID=39739795

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200908230A UA97971C2 (ru) 2007-06-08 2008-06-04 Препарат невирапина пролонгированного высвобождения

Country Status (28)

Country Link
US (1) US8460704B2 (ru)
EP (1) EP2155169B1 (ru)
JP (1) JP5417662B2 (ru)
KR (1) KR101017862B1 (ru)
CN (1) CN101784263B (ru)
AR (1) AR066924A1 (ru)
AU (1) AU2008262031B2 (ru)
BR (1) BRPI0811732A2 (ru)
CA (1) CA2687491C (ru)
CL (1) CL2008001678A1 (ru)
CO (1) CO6150128A2 (ru)
DK (1) DK2155169T3 (ru)
EA (1) EA018377B1 (ru)
EC (1) ECSP099561A (ru)
ES (1) ES2574836T3 (ru)
HU (1) HUE028598T2 (ru)
IL (1) IL199924A0 (ru)
MA (1) MA31430B1 (ru)
MX (1) MX2009007764A (ru)
NZ (1) NZ578664A (ru)
PE (2) PE20090371A1 (ru)
PL (1) PL2155169T3 (ru)
TN (1) TN2009000510A1 (ru)
TW (1) TWI419716B (ru)
UA (1) UA97971C2 (ru)
UY (1) UY31128A1 (ru)
WO (1) WO2008154234A2 (ru)
ZA (1) ZA200904939B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149159A (en) 2005-11-15 2013-07-31 Hoffmann La Roche Method for treating joint damage
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
AU2008262031B2 (en) 2007-06-08 2011-08-25 Boehringer Ingelheim International Gmbh Extended release formulation of nevirapine
JP2011526303A (ja) 2008-06-27 2011-10-06 デューク ユニバーシティ エラスチン様ペプチドを含む治療剤
US20140193491A1 (en) 2011-05-30 2014-07-10 Cipla Limited Pharmaceutical antiretroviral composition
CA2846209C (en) * 2011-08-24 2022-04-05 Phasebio Pharmaceuticals, Inc. Systemic sustained release formulation comprising elastin­like peptide repeating sequence and protein active agent
CA2866133A1 (en) * 2012-03-05 2013-09-12 Cipla Limited Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
CN104523630B (zh) * 2015-01-22 2017-08-25 山东新时代药业有限公司 一种奈韦拉平片剂
EP3153157A1 (en) 2015-10-09 2017-04-12 Teva Pharmaceutical Works Private Limited Company Pharmaceutical composition for prolonged release of nevirapine

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
CA2030056C (en) 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US6514530B2 (en) * 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape
DK1035834T3 (da) * 1997-12-05 2002-07-08 Alza Corp Osmotisk doseringsform omfattende en første og anden coating
AU765909C (en) * 1998-12-17 2004-09-23 Alza Corporation Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
EP1169024B1 (en) * 1999-03-31 2005-12-21 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
KR100820605B1 (ko) * 1999-09-24 2008-04-08 얀센 파마슈티카 엔.브이. 항바이러스 조성물
JP2003516345A (ja) 1999-12-09 2003-05-13 アルザ・コーポレーション 抗ウイルス剤
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
WO2002092095A1 (en) 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
US20030050620A1 (en) 2001-09-07 2003-03-13 Isa Odidi Combinatorial type controlled release drug delivery device
AU2003287666A1 (en) 2002-11-13 2004-06-03 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
WO2004112724A2 (en) 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating hiv
DE602004005734T2 (de) 2003-10-01 2007-12-27 Lupin Ltd., Mumbai Pharmazeutische zusammensetzung mit kontrollierter freisetzung und verfahren zu ihrer herstellung
PT1696822E (pt) 2003-11-13 2010-04-28 Psivida Inc Implante de libertação controlada injectável com um núcleo de matriz biocorrosível e crosta biocorrosível
CA2577288C (en) * 2004-09-02 2010-11-30 Janssen Pharmaceutica N.V. Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
US20110104267A1 (en) * 2005-04-25 2011-05-05 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
CA2613407A1 (en) 2005-06-29 2007-01-04 Panacea Biotec Ltd. Pharmaceutical sustained release compositions and processes thereof
EP1906937B1 (en) 2005-07-22 2016-10-19 Rubicon Research Pvt Ltd. Novel dispersible tablet composition
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
CA2625776A1 (en) * 2005-10-14 2007-04-26 Microdose Technologies, Inc. Pharmaceutical packaging of an oral dosage combination
AU2008262031B2 (en) 2007-06-08 2011-08-25 Boehringer Ingelheim International Gmbh Extended release formulation of nevirapine

Also Published As

Publication number Publication date
CN101784263B (zh) 2012-11-07
US20100278918A1 (en) 2010-11-04
UY31128A1 (es) 2009-01-30
EA200900958A1 (ru) 2010-04-30
TWI419716B (zh) 2013-12-21
PE20090371A1 (es) 2009-04-24
AU2008262031A1 (en) 2008-12-18
CA2687491A1 (en) 2008-12-18
HUE028598T2 (en) 2016-12-28
MX2009007764A (es) 2009-09-10
WO2008154234A2 (en) 2008-12-18
CA2687491C (en) 2011-09-20
BRPI0811732A2 (pt) 2014-11-18
PE20131035A1 (es) 2013-10-01
AR066924A1 (es) 2009-09-23
ZA200904939B (en) 2010-04-28
CN101784263A (zh) 2010-07-21
WO2008154234A9 (en) 2009-11-26
ECSP099561A (es) 2009-09-29
WO2008154234A3 (en) 2010-01-21
US8460704B2 (en) 2013-06-11
JP5417662B2 (ja) 2014-02-19
ES2574836T3 (es) 2016-06-22
CL2008001678A1 (es) 2009-09-11
EP2155169A2 (en) 2010-02-24
MA31430B1 (fr) 2010-06-01
CO6150128A2 (es) 2010-04-20
HK1145806A1 (en) 2011-05-06
TN2009000510A1 (en) 2011-03-31
PL2155169T3 (pl) 2016-09-30
DK2155169T3 (en) 2016-06-13
EA018377B1 (ru) 2013-07-30
EP2155169B1 (en) 2016-03-23
AU2008262031B2 (en) 2011-08-25
TW200916127A (en) 2009-04-16
KR101017862B1 (ko) 2011-03-04
JP2010520891A (ja) 2010-06-17
KR20100020447A (ko) 2010-02-22
NZ578664A (en) 2011-11-25
IL199924A0 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
JOP20180102A1 (ar) مركب صيدلاني
MX2011007267A (es) Composiciones farmaceuticas que comprenden derivados de 2-oxo-1-pirrolidina.
TN2009000510A1 (en) Extended release formulation of nevirapine
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
PH12012501346A1 (en) Heteroaryl compounds and uses thereof
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
IL224288A (en) Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use
MY153915A (en) Organic compounds
WO2011032169A3 (en) Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
LT2373681T (lt) Albiglutido farmacinės kompozicijos
PL2079446T3 (pl) Preparat paliperidonu o przedłużonym uwalnianiu
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
EP2129672A4 (en) ESTER AND CARBAMATE AZAADAMANTANE DERIVATIVES AND METHODS OF USE
IN2012DN03404A (ru)
MX2010008852A (es) Formulaciones de flibanserina.
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
EP2296687A4 (en) PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN DOPAMINE CONJUGATES
MY165088A (en) Pharmaceutical compositions comprising alisporivir
IL212171A (en) 1-Phenylpyrol compounds, pharmaceuticals containing them and their use
ZA201101053B (en) Pharmaceutical compositions of samatotrophic hormones
AP2012006119A0 (en) Pharmaceutical composition of isoniazid.
MX2012008253A (es) Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida.
EP2568810A4 (en) COMPOSITIONS OF DARUNAVIR